secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quince Therapeutics, Inc. (QNCX)
CIK:        0001662774
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001193125-24-165631
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Quince Therapeutics receives Nasdaq delisting notice for bid price non-compliance
--------------------------------------------------------------------------------

- Received Nasdaq notice for non-compliance with $1.00 minimum bid price requirement.
- Closing bid price below $1.00 for 34 consecutive trading days.
- Has until December 17, 2024 to regain compliance by closing at $1.00 for 10 consecutive days.
- May transfer to Nasdaq Capital Market for additional 180-day compliance period if eligible.
- Company will monitor closing bid price; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662774/000119312524165631/0001193125-24-165631-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662774/000119312524165631/d835941d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-165631

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer